Evidence map›Paper›PMID 37764022›Full record

ArticleMicroorganisms2023

Amir Nutman, Elizabeth Temkin, Liat Wullfhart, Vered Schechner, Mitchell J Schwaber, Yehuda Carmeli

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Treating Extensively Drug-ResistantPathogens (Basel, Switzerland) · 2026
    Review
  3. Epidemiology of Carbapenem-ResistantJournal of clinical medicine · 2026
    Article
  4. Article
  5. Article
  6. The Molecular Characterization ofMicroorganisms · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Amir NutmanNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.ORCID 0000-0002-1599-2618
Elizabeth TemkinNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.
Liat WullfhartNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.
Vered SchechnerNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.
Mitchell J SchwaberNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.
Yehuda CarmeliNational Institute for Antibiotic Resistance and Infection Control, Ministry of Health, Tel Aviv 6423906, Israel.
Tel Aviv University · ILIsrael Ministry of Health · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acinetobacter baumanniiantimicrobial resistancebloodstream infectioncarbapenem resistanceincidencemortalitypopulation-based study

Identifiers

PMID37764022
PMCPMC10534809
OpenAlexW4386250821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.